Interestingly, this finding is corroborated by data from MDSGene, showing early-onset PD in approximately one-third of patients with pathogenic or likely pathogenic LRRK2 variants, which further supports the pathogenicity of p.R1067Q [20]. The gene discussed is LRRK2; the disease is Parkinson disease.